Sort
10,766 grants matching “checkpoint inhibitor”
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$607,124Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2022 · CA
Role of inflammation, innate resistance, and immunity in carcinogenesis
$607,045Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy andImmunotherapy
$606,856Bo Lu · University Of Missouri-Columbia · R01 · FY2023 · CA
Understanding the role of autophagy-regulated cell death in the escape from replicative crisis
$606,831Jan Karlseder · Salk Institute For Biological Studies · R01 · FY2024 · CA
Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer
$606,797Jia Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment
$606,587Mizuki Nishino · Brigham And Women'S Hospital · R01 · FY2017 · CA
Biomarkers for acute interstitial nephritis in humans
$606,218Dennis G. Moledina · Yale University · R01 · FY2023 · DK
Long-Term Cardiovascular Sequelae of Cancer Immunotherapies
$606,001Javid J Moslehi · University Of California, San Francisco · R01 · FY2024 · HL
In situ single cell imaging
$605,767Feng Gao · Dotquant, Llc · R44 · FY2020 · CA
In situ single cell imaging
$605,767Hong Yan Liu · Dotquant, Llc · R44 · FY2021 · CA
Development of selective HDAC6 inhibitors to improve cancer immunotherapy
$605,710Alejandro V Villagra · Georgetown University · R01 · FY2023 · CA
RIG-I Activating Nanoparticles for Immunopotentiation
$605,681John Tanner Wilson · Vanderbilt University · R01 · FY2022 · EB
Molecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response
$605,520Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · CA
Molecular Digital CytoImaging for Leukemia Drug Screening
$605,517Tothu Q Vu · Oregon Health & Science University · R01 · FY2018 · CA
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy
$605,357Simon Young · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · DE
Therapeutic approaches for LKB1-deficient non-small cell lung cancer
$605,252John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Therapeutic approaches for LKB1-deficient non-small cell lung cancer
$605,252John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Therapeutic approaches for LKB1-deficient non-small cell lung cancer
$605,252John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Immune Exclusion in Cancer Immunotherapy
$604,941Riyue Bao · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DE
Immune Exclusion in Cancer Immunotherapy
$604,941Riyue Bao · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DE
Immune Exclusion in Cancer Immunotherapy
$604,941Riyue Bao · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DE
Focused ultrasound-mediated intranasal brain drug delivery technique (FUSIN)
$604,694Hong Chen · Washington University · R01 · FY2025 · EB
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy
$604,257Donald Ym Leung · National Jewish Health · U01 · FY2021 · AR
Understanding and targeting the DNA replication stress in cancer cells
$603,796Lee Zou · Duke University · R35 · FY2024 · CA
Re-wiring PDAC Tumor Immunity Through Dendritic Cells
$603,590David G Denardo · Washington University · R01 · FY2022 · CA